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A New Method for the Analysis of Cohort
Studies: Implications of the Multistage
Theory of Carcinogenesis Applied to
Occupational Arsenic Exposure
by Charles C. Brown* and Kenneth C. Chut
Implications of the multistage theory of carcinogenesis for evaluating the effect of exposure to
carcinogens in the workplace are described. This theory predicts different patterns of excess risk re-
lated to duration of exposure, age at initial exposure, and follow-up time since exposure stopped, de-
pending upon which stage of the carcinogenic process is affected by the carcinogen, i.e., action at an
early stage or a late stage. New statistical methodologies are proposed to examine these patterns
and are applied to the lung cancer mortality experience from a cohort study of smelter workers ex-
posed to arsenic. Under this multistage hypothesis, the results indicate that arsenic exerts a def-
inite late stage effect though an additional effect at the initial stage cannot be ruled out. The pos-
sibilities of biased conclusions resulting from incomplete exposure histories and lack of smoking in-
formation are also discussed as well as implications of these results to experimental animal studies.
Introduction
A multistage theory of carcinogenesis was first
proposed by Muller (1) and Nordling (2) to a-ccount
for the observation that mortality rates for many
forms of adult human cancer increase with the fifth
or sixth power of age. Many different multievent
theories have also been proposed and are summar-
ized by Whittemore and Keller (3). A recent two-
event theory of carcinogenesis to describe the age-
specific occurrence of both childhood and adult tu-
mors has been proposed by Moolgavkar and Venzon
(4). These quantitative theories of carcinogenesis re-
late the frequency and time to occurrence of detect-
able tumors to the concentration of the carcinogen,
the duration of exposure to the carcinogen, the age
and susceptibility of the host, and other related fac-
tors.
According to the general multistage theory, a
single cell gives rise to a malignant tumor only after
it has undergone a number of sequential, heritable
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changes. These cellular changes represent stages in
the carcinogenic process and are characterized as
being of slow and improbable occurrence. This
transformation period is then followed by a promo-
tion and growth period during which the trans-
formed cell produces a colony of descendants by
rapid cell division. This general formulation has
been shown to describe a number of epidemiological
and experimental observations.
As noted earlier, the risk of adult cancer has
been found to increase progressively as a function
of the fifth or sixth power of age (5). The multistage
theory indicates that this increase of risk with age
is a reflection of increasing time exposure to the
carcinogenic process began rather than an aging
phenomenon, a prediction which has been verified
experimentally (6). Another fundamental aspect of
this theory is the general characterization of the
early and late stages of this multievent cellular
transformation process. Under the multistage the-
ory, initiators can be thought of as carcinogens
which affect the first stage, or more generally an
early stage in the carcinogenic process. These car-
cinogens are characterized by a long latency period
due to the time required to progress through the re-
maining stages. The latency period, as defined byBROWNAND CHU
Armitage and Doll (7), is the time between first ex-
posure and the subsequent clinical appearance of
cancer. On the other hand, cocarcinogens which act
late in the transformation process are characterized
as having a shorter latency period than initiators.
In the present study, we propose statistical meth-
odologies to quantify these concepts of the multi-
stage theory, laying a foundation for the analysis of
epidemiologic cohort studies. In our example, exam-
ining the patterns of excess lung cancer mortality in
a cohort of men occupationally exposed to arsenic,
our analysis encompasses three primary objectives:
(1) determination of the factors which are associated
with this excess risk to man; these factors include
level of carcinogenic exposure, duration of expo-
sure, age at initial exposure, and time since expo-
sure ceased; (2) interpretation of the carcinogenic
mechanism of action of arsenic, based on the pre-
ceding findings; and (3) utilization of these findings
for the assessment of human carcinogenic risk for
different exposure situations.
Materials
This analysis is based on an epidemiologic study
by Lee and Fraumeni of men occupationally ex-
posed to arsenic studied (8). The original study in-
cluded 8047 white males employed as copper smel-
ter workers for 12 or more months before Decem-
ber 31, 1956 and whose mortality experience was
observed from January 1, 1938 to December 31,
1963. These workers were exposed to various levels
of arsenic trioxide and contaminants, such as sulfur
dioxide, in the atmosphere. Various work areas in
the smelter were categorized into three groups,
heavy, medium, and light or unspecified with re-
spect to their relative amounts of atmospheric ar-
senic. Lee and Fraumeni found a significant excess
number ofrespiratory cancers which was associated
with both level and duration of exposure.
Due to a few missing records, the data used for
this analysis consist of 8014 workers (132,790
person-years at risk) for whom 139 lung cancer
deaths were observed and 44.2 were expected
(based on U.S. white male age- and calendar time-
specific mortality rates). The cause of death infor-
mation for the current data were recoded to the 8th
Revision of the International Classification of Dis-
eases (ICD for lung cancer = 162).
Methods
Armitage and Doll (7) formulated the multistage
theory in mathematical terms as a stochastic pro-
cess which assumes that a single cell can generate a
malignant tumor only after it has undergone a
certain number k of heritable changes which occur
in a specific order. The Armitage-Doll theory
concludes that the background or spontaneous age-
specific incidence of adult cancers in the absence of
any specific carcinogenic exposure, INt), at age t is
approximately given by Eq. (1)
1(t) rv aa2 . . . aktk-l (1)
where ai (i= 1,... ,k) represents the rate of occur-
rence of the ith cellular change, and the time from
the last cellular event required for growth to a de-
tectible tumor is assumed to be negligible with re-
spect to the total time t. These ae are assumed to be
independent of age for a particular individual but
may vary among individuals due to different ge-
netic and environmental factors.
When an individual is exposed to an additional
carcinogenic insult, Whittemore (9) assumes that the
cellular event rates become ai+Pic(t), where i = 1,
..., k and where c(t) represents the concentration
of the additional carcinogenic exposure at age t. It
should be noted that some of the pi may be zero, in-
dicating that this particular carcinogen does not af-
fect the ith cellular event. These event rates may be
written as,
at + f3ic(t) = aj[l +ric(t)]
where ri=Pi/ai represents the relative increase in
the ith cellular event per unit of carcinogenic expo-
sure. When the additional carcinogenic insult occurs
over only a fraction of the individual's lifetime, the
pattern of excess cancer risk, i.e., the overall risk
minus the background risk, has been shown to be
dependent upon the stage(s) of the process, i.e., cel-
lular events affected by the carcinogen (9, 10).
Therefore, in light of the multistage theory,
examination of the patterns observed for a par-
ticular carcinogenic exposure may provide in-
formation on its mechanism of action, i.e., which
stage(s) of the carcinogenic process are affected by
the carcinogen. Doll (11) and Doll and Peto (12) have
studied the evolution of lung cancer risk in smokers
and ex-smokers, whereas Whittemore (9) and Day
and Brown (10) examined both epidemiologic and ex-
perimental data on other carcinogenic exposures.
For the carcinogens examined, they found some
which appear to influence only early stages, some
which influence only late stages, and some which ap-
pear to influence both early and late stages.
As shown by Whittemore and Day and Brown,
for exposure to a carcinogen at a constant level, the
excess risk is determined by the duration of expo-
sure, the age at which exposure begins, and for
those individuals whose exposure has ceased, the
time since exposure stopped. For continuous carci-
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nogenic exposure at a constant concentration c be-
ginning at age to, the excess age-specific cancer risk
E(t) at age t when only the first stage is affected is
given by Eq. (2):
E(t)h-c(t-to)k- 1 = cdk- 1 (2)
where d is the duration of exposure at level c and k
represents the number of stages in the process.
This relationship indicates that if the carcinogen af-
fects only the first stage of the carcinogenic process,
then the excess risk should be proportional to the
concentration of the carcinogen and an increasing
function of the duration of exposure. This relation-
ship also shows that the excess risk is independent
of age started exposure, to, for fixed concentration
and duration of exposure.
On the other hand, if the carcinogen affects only
the penultimate (next to last) stage of the process,
then the excess cancer risk at age t is given by,
E(t)r\c(tk- 1 tok- 1) = c[(d + to)k- 1 tok- 1] (3)
This relationship indicates that the age-specific ex-
cess cancer risk is proportional to the exposure con-
centration c and is an increasing function of both
the duration of exposure for fixed age started and
of age started exposure for fixed duration. Thus an
examination of the excess risk as a function of age
started exposure, standardized for concentration
and duration of exposure, will indicate whether the
carcinogen affects an early stage (no relationship) or
a late stage (increasing trend).
Similar inferences can be made by examining the
excess risk patterns for those individuals who have
stopped their exposure. When the carcinogenic ex-
posure begins at age to, continues at a constant con-
centration c for an exposure duration of length d,
then stops, and follow-up continues for a period of
length f, the excess age-specific cancer risk at age
t = to + d+fis given by Eq. (4)
E(t)vc[(d +Dk - 1 fk- 1] (4)
when only the first stage is affected by the carcino-
gen, and by Eq. (5)
E(t)vc[(d + to)k- 1 - tok - 1)] (5)
when only the penultimate stage is affected. These
relationships indicate that the age-specific excess
risk is proportional to the concentration of exposure
c and is an increasing function of exposure duration
d for any affected stage, early or late. However,
when the carcinogen affects only the first stage
then the excess risk is independent of the age expo-
sure began, to, for fixed duration and follow-up time
since exposure stopped. When the carcinogen af-
fects only the penultimate stage then the excess
risk is independent of follow-up time since exposure
stopped f for fixed duration and age started expo-
sure. It should be noted that Eq. (2) is a special case
of Eq. (4) with follow-up time since exposure
stopped, f= 0, and Eqs. (3) and (5) are identical.
Thus, an examination of the excess cancer risk as a
function of age started exposure standardized for
concentration, duration, and follow-up time and as
a function of follow-up time since exposure stopped,
standardized for concentration, duration, and age
started exposure, will provide information on
whether an early or later stage of the cellular trans-
formation process is affected by the carcinogen. The
excess risk being independent of age started expo-
sure would imply an early-stage effect, while inde-
pendence of follow-up time would imply a late-stage
effect.
Since the multistage theory predicts different
patterns of excess risk for individuals continuously
exposed and individuals for whom exposure has
ceased, the cohort of workers was examined in two
ways. First, the excess lung cancer risk for this co-
hort was studied while the individuals were ex-
posed to arsenic. Second, we also studied the excess
lung cancer risk for those individuals who ended
their employment at this smelter, i.e., with cessa-
tion of exposure more than one year before their
death. Since many workers who died of lung cancer
or other diseases died shortly after termination of
employment (employment termination being
"caused" by their illness), we have assumed an
illness period of one year to calculate the person-
years at risk for individuals while exposed. Thus, an
individual who died within one year of employment
termination would contribute all his person-years
only to the continuously exposed group, whereas an
individual who died after more than one year had
elapsed since employment termination would con-
tribute his person-years at risk to both the continu-
ously exposed and stopped exposure groups. We
examined other illness period durations and found
substantially similar results.
The continuously exposed group consists of all
8014 workers who contributed 85,273 person-years
at risk during their periods of exposure. There were
70 deaths from lung cancer found and 22.7 expected
in this group. The group of workers for whom em-
ployment had terminated consists of 4676 workers
who contributed 47,517 person-years at risk during
the period they were no longer employed at this
smelter. There were 69 deaths from lung cancer
found and 21.6 expected in this group. The expected
numbers of lung cancers are based on U.S. age-spe-
cific while male lung cancer mortality rates during
the period 1940-1960 (13). The expected cancer mor-
tality risk was calculated for each individual based
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on his age and calendar year of observation (in 5-
year age and calendar year groups), and these indi-
vidual expected risks were used to represent the
spontaneous or background lung cancer risk used in
the examination of excess mortality rates. Since we
were unsure that these background mortality esti-
mates based on national statistics were applicable
to this particular cohort of workers, we performed
our analyses by assuming different multiplicative
factors (between 1/2 and 2) of the U.S. national rates
with qualitatively similar results (i.e., we applied the
same factor to the U.S. national rates to obtain dif-
ferent background mortality estimates).
Tables 1 and 2 show summary numbers of indi-
viduals, their numbers of person-years at risk, the
observed and expected numbers of lung cancer
deaths, and the excess lung cancer mortality rates
for the continuously exposed and stopped exposure
groups, respectively (see Tables 3 and 4 for more
detail). These data are categorized into five age
started exposure groups (<20, 20-29, 30-39, 40-49,
and >50), five duration of exposure groups (<10
years, 10-19, 20-29, 30-39, and ;40 years), three
follow-up time since exposure stopped groups (<10
Table 1. Number of individuals, person-years at risk, observed and expected number of lung cancer deaths, and crude excess
lung cancer mortality rate (continuously exposed group).
Number of Person-yr No. lung cancer deaths Crude excess
persons at risk Obs. Exp. mortality rate x 10-4
Age at initial employment
<20 2211 31083.9 14 5.74 2.66
20-29 2887 29683.1 30 6.17 8.03
30-39 1552 14185.0 12 4.29 5.43
40-49 938 7557.9 8 3.99 5.31
.50 426 2863.1 6 2.48 12.3
Years ofemploymenta
<10 6171 38720.4 7 4.57 0.63
10-19 3394 20276.4 8 4.16 1.89
20-29 2175 13253.9 14 4.00 7.55
30-39 1354 9296.2 21 6.09 16.0
240 855 3826.2 20 3.86 42.2
Exposure level category
Light 6006 60368.6 33 15.44 2.91
Medium 1623 19735.7 27 5.61 10.8
Heavy 385 5268.8 10 1.63 15.9
aIndividuals may contribute to more than one duration category.
Table 2. Number of individuals, person-years at risk, observed and expected number of lung cancer deaths, and crude excess
lung cancer mortality rate (terminated exposure group).
Number of Person-yr No. lung cancer deaths Crude excess
persons at risk Obs. Exp. mortality rate x 10'
Age at initial employment
<20 1152 10944.5 8 2.59 4.94
20-29 1740 18985.3 25 5.40 10.3
30-39 922 9710.3 18 5.02 13.4
40-49 574 5452.8 14 5.17 16.2
.50 288 2424.2 4 3.37 2.59
Years of employmenta
<10 2824 33802.9 21 10.23 3.19
10-19 822 7066.6 10 3.23 9.58
20-29 304 2338.5 9 1.97 30.1
30-39 305 1813.9 10 2.43 41.7
240 421 2495.2 19 3.70 61.3
Years after employment terminationa
<10 4676 34905.2 48 14.27 9.66
10-19 2032 12006.7 20 6.80 11.0
.20 365 605.2 1 0.49 8.47
Exposure level category
Light 3671 38375.3 40 16.72 6.07
Medium 827 7496.3 22 3.84 24.2
Heavy 178 1645.6 7 1.00 36.5
aIndividuals may contribute to more than one follow-up time category.
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years, 10-19, and > 20 years), and three level of ex-
posure groups. The exposure level categories corre-
spond to those defined by Lee and Fraumeni (8): the
"heavy" exposure group consists of individuals with
one or more years exposure at a worksite associ-
ated with "heavy" exposure (385 individuals); the
"medium" exposure group consists of those individ-
uals not in the "heavy" group with one or more
years exposure at a worksite associated with
"heavy" or "medium" exposure (1621 individuals);
the remainder made up the "light" exposure cate-
gory (6008 individuals).
We examined the attributable lung cancer mor-
tality risk/person-year, i.e., (observed number- ex
pected number)/person-years at risk, as a function of
the variables of interest, age at initial exposure, du-
ration of exposure, time since cessation of exposure,
and concentration level of exposure. Since the cate-
gorizations of these variables are related to one
another (age at initial exposure and duration of ex-
Table 3. Observed and expected lung cancer deaths and person-years by level of exposure,
duration of employment and age at initial employment.
Exposure Age at
level initial Duration of employment, yrs
group employment 0-9 10-19 20-29 30-39 40 +
High <20 Obs 0 0 0 3 0
20-29
30-39
40-49
50 +
Medium <20
20-29
30-39
40-49
50 +
Low <20
20-29
30-39
40-49
50 +
Exp
Pyr
Obs
Exp
Pyr
Obs
Exp
Pyr
Obs
Exp
Pyr
Obs
Exp
Pyr
Obs
Exp
Pyr
Obs
Exp
Pyr
Obs
Exp
Pyr
Obs
Exp
Pyr
Obs
Exp
Pyr
Obs
Exp
Pyr
Obs
Exp
Pyr
Obs
Exp
Pyr
Obs
Exp
Pyr
Obs
Exp
Pyr
0.001
206
0
0.008
624
0
0.030
398
0
0.083
210
0
0.066
78.0
0
0.010
1801
0
0.035
2636
0
0.167
1939
1
0.435
1190
1
0.262
295
0
0.056
8524
0
0.115
9951
0
0.390
5218
2
1.29
3703
3
1.62
1945
0.009
408
0
0.051
637
0
0.077
207
0
0.054
80.0
0
0.027
23.2
0
0.039
1763
0
0.118
1622
0
0.473
1137
2
0.414
448
0
0.076
71.2
0
0.117
5249
0
0.334
4724
3
0.802
2218
1
1.18
1319
2
0.385
371
0.065
588
2
0.164
495
3
0.106
155
0
0.034
49,1
0
0.0
0.0
1
0.171
1500
2
0.331
1099
1
0.329
438
0
0.098
98.9
0
0.011
14.5
1
0.478
4038
2
0.892
2965
1
0.937
1364
1
0.344
386
0
0.041
65.4
0.249
499
0
0.277
308
0
0.053
59.1
0
0.007
6.88
0
0.0
0.0
4
0.591
1206
4
0.717
951
3
0.161
194
0
0.010
12.1
0
0.0
0.0
1
1.59
3175
5
1.74
2117
0
0.662
715
1
0.035
52.7
0
0.0
0.0
0.193
172
2
0.082
64.4
0
0.001
0.86
0
0.0
0.0
0
0.0
0.0
1
0.597
579
7
0.514
654
0
0.045
68.2
0
0.0
0.0
0
0.0
0.0
3
1.57
1376
6
0.796
834
1
0.062
74.6
0
0.001
2.00
0
0.0
0.0
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posure, and exposure duration and follow-up time
are highly negatively associated and exposure dura-
tion is positively associated with exposure level),
the excess cancer rates for one variable should be
standardized for the other variables in order to ob-
tain unconfounded rates. The qualitative examina-
tion of these unconfounded rates forms the basis for
our deductions concerning the mechanism of action
of arsenic as a carcinogen, i.e., the conclusions re-
garding early and/or late affected stages.
Since the estimated excess lung cancer rates in
Tables 3 and 4 are based on substantially different
person-years at risk (a number of the cells in these
tables have no person-years), we used the indirect
method of standardization based on standard rates
derived from the data itself. Our procedure is a di-
rect extension of that proposed by Mantel and
Stark (14) and is described in detail in the statistical
appendix. Since this procedure does not provide for
statistical hypothesis tests of interest (e.g., homoge-
neity or equality of the adjusted rates, or trend of
the rates over the categorization), a statistical meth-
odology for the analysis of excess cancer risk has
been developed and is also described in the statisti-
cal appendix. This methodology is shown in the ap-
pendix to correspond to the familiar Mantel-Haen-
szel methods (15, 16) for the analysis of overall can-
cer risk.
In addition to these qualitative methodologies,
these data are also examined quantitatively by fit-
Table 4. Observed and expected lung cancer deaths and person-years by degree of exposure, duration of employment,
age at initial employment and length of follow-up for stopped exposure group.
Age at High dose Medium dose
ge atHi
initial Follow-up period, yr Follow-up period, yr
Duration, yr employment 0-9 10-19 20 + 0-9 10-19 20 +
0-9 <20 Obs 0 0 0 0 0 0
10-19
20-29
Exp
Pyr
20-29 Obs
Exp
Pyr
30-39 Obs
Exp
Pyr
40-49 Obs
Exp
Pyr
50 + Obs
Exp
Pyr
<20 Obs
Exp
Pyr
20-29 Obs
Exp
Pyr
30-39 Obs
Exp
Pyr
40-49 Obs
Exp
Pyr
50+ Obs
Exp
Pyr
<20 Obs
Exp
Pyr
20-29 Obs
Exp
Pyr
30-39 Obs
Exp
Pyr
40-49 Obs
Exp
Pyr
0.000
25.0
0
0.007
240
0
0.028
200
1
0.063
91.6
0
0.030
26.7
0
0.004
71.0
0
0.019
95.6
0
0.015
35.6
0
0.015
9.6
0
0.026
29.0
0
0.013
33.5
1
0.022
38.6
1
0.040
29.4
0
0.027
18.6
0.001
14.3
0
0.026
130
1
0.057
95.8
0
0.053
35.5
0
0.018
9.5
0
0.016
49.3
0
0.028
38.7
0
0.005
4.7
0
0.0
0.0
0
0.005
4.8
0
0.008
10.5
1
0.007
5.3
0
0.0
0.0
0
0.0
0.0
0.0
0.0
0
0.002
7.6
0
0.006
5.0
0
0.003
1.2
0
0.0
0.0
0
0.007
8.5
0
0.009
6.0
0
0.0
0.0
0
0.0
0.0
0
0.0
0.0
0
0.0
0.0
0
0.0
0.0
0
0.0
0.0
0
0.0
0.0
0.007
627
0
0.036
1228
0
0.151
819
0
0.296
4428
0
0.186
1142
0
0.015
2256
0
0.046
3317
1
0.098
151
2
0.153
1106
0
0.112
67.0
0
0.046
193
2
0.051
92.3
1
0.050
39.9
0
0.105
78.4
0.017
237
0
0.090
560
2
0.263
400
1
0.185
126
0
0.072
37.1
0
0.022
70.0
1
0.072
117
0
0.059
42.3
0
0.0
0.0
0
0.0
0.0
0
0.059
75.3
1
0.031
19.4
0
0.0
0.0
0
0.000
0.2
0.002
11.8
0
0.011
25.8
0
0.004
3.5
0
0.001
0.8
0
0.0
0.0
0
0.005
6.6
0
0.005
2.2
0
0.005
2.6
0
0.0
0.0
0
0.0
0.0
0
0.007
3.3
0
0.0
0.0
0
0.0
0.0
0
0.0
0.0
Low dose
Follow-up period, yr
0-9 10-19 20 +
0 1 0
0.043 0.086 0.018
4012 1376 93.9
0 0 0
0.230 0.604 0.083
7702 3540 194
1 4 0
0.716 1.16 0.093
4093 1785 78.6
5 2 0
1.62 1.62 0.050
2645 1095 23.6
3 1 0
1.61 0.675 0.008
1275 361 3.7
0 0 0
0.087 0.154 0.043
1619 490 47.3
0 2 1
0.237 0.339 0.084
1509 482 56.8
2 0 0
0.312 0.128 0.005
514 91.0 2.3
0 0 0
0.496 0.067 0.0
364 38.6 0.0
1 0 0
0.521 0.015 0.0
354 8.0 0.0
0 0 0
0.096 0.166 0.018
3.67 174 10.3
0 0 0
0.248 0.146 0.008
370 103 3.5
0 0 0
0.293 0.078 0.007
224 44.8 3.4
1 1 0
0.300 0.044 0.003
257 34.9 2.1
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Table 4 (Continued)
Age atHigh dose Medium dose Low dose
ge atH __
initial Follow-up period, yr Follow-up period, yr Follow-up period, yr
Duration, yr employment 0-9 10-19 20 + 0-9 10-19 20 + 0-9 10-19 20 +
20-29 50 + Obs 0 0 0 0 0 0 0 0 0
Exp 0.0 0.0 0.0 0.011 0.0 0.0 0.067 0.016 0.0
Pyr 0.0 0.0 0.0 13.3 0.0 0.0 78.1 15.8 0.0
30-39 <20 Obs 0 0 0 0 0 0 1 0 0
Exp 0.011 0.0 0.0 0.046 0.000 0.0 0.179 0.035 0.0
Pyr 11.9 0.0 0.0 48.8 0.1 0.0 196 18.3 0.0 20-29 Obs 0 0 0 2 0 0 2 1 0
Exp 0.120 0.009 0.0 0.189 0.038 0.0 0.480 0.049 0.0
Pyr 75.5 5.0 0.0 155 23.9 0.0 341 29.8 0.0
30-39 Obs 0 1 0 0 0 0 2 0 0
Exp 0.079 0.007 0.0 0.186 0.014 0.0 0.841 0.076 0.0
Pyr 47.1 3.4 0.0 132 9.1 0.0 571 53.4 0.0
40-49 Obs 0 0 0 0 0 0 1 0 0
Exp 0.0 0.0 0.0 0.015 0.0 0.0 0.055 0.0 0.0
Pyr 0.0 0.0 0.0 14.7 0.0 0.0 77.2 0.0 0.0
50+ Obs 0 0 0 0 0 0 0 0 0
Exp 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Pyr 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
40 + <20 Obs 0 0 0 4 0 0 2 0 0
Exp 0.070 0.0 0.0 0.340 0.031 0.001 0.930 0.010 0.0
Pyr 40.3 0.0 0.0 198 17.6 0.5 524 6.6 0.0
20-29 Obs 1 0 0 3 1 0 6 0 0
Exp 0.121 0.004 0.0 0.600 0.043 0.0 1.224 0.081 0.0
Pyr 71.7 2.4 0.0 491 36.5 0.0 805 65.4 0.0
30-39 Obs 0 0 0 1 0 0 1 0 0
Exp 0.012 0.008 0.0 0.059 0.001 0.0 0.161 0.004 0.0
Pyr 12.3 6.2 0.0 68.9 1.1 0.0 136 6.3 0.0
40-49 Obs 0 0 0 0 0 0 0 0 0
Exp 0.0 0.0 0.0 0.0 0.0 0.0 0.004 0.0 0.0
Pyr 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0
50+ Obs 0 0 0 0 0 0 0 0 0
Exp 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Pyr 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
ting the multistage model predictions in Eqs. (2)-(5)
to the observed data by the use of GLIM [General-
ized Linear Interactive Modelling program (17)]. For
these analyses, the observed numbers of lung can-
cers given in Tables 3 and 4 are assumed to be Pois-
son variates with mean value given by the sum of
the expected numbers of cancers and the number of
person-years at risk times some excess risk function
derived from the multistage theory of carcinogene-
sis, i.e., = E+NF(to,d,f,c), where E = expected
number of cancers, N= person-years of risk and F is
a function taking the form of Eqs. (2)-(5). The covari-
ate values of to, d, andf used in this regression anal-
ysis were determined for each cell of Tables 3 and 4
by weighted averages, weighted by the person-
years at risk within each cell.
Results
For individuals continuously exposed to arsenic,
the multistage theory indicates that the excess risk
of lung cancer mortality will be an increasing func-
tion of exposure duration and concentration, and
may or may not depend upon the age at which expo-
sure began. Therefore, the indirect adjustment
method was employed on the data in Table 3 to pro-
vide excess lung cancer mortality rates for each of
the three factors of interest (age at initial exposure,
duration of exposure, level of exposure) adjusted for
the possible confounding effects of the other two
factors. These unconfounded rates are given in
Table 5. As these results show, the excess lung can-
cer mortality is an increasing function of all three
factors, and their associated test statistics, given in
Table 5, are highly significant (one degree of free-
dom chi-square tests for trend are 13.2 for exposure
level, 49.1 for exposure duration, and 13.1 for age at
initial exposure). The excess lung cancer mortality
rates for age at initial exposure adjusted for dura-
tion and level of exposure range from 0.76 x 104,
for those who started employment at this smelter
before 20 years of age, to 71.1 x 10', for those who
started at or beyond 50 years of age. The adjusted
excess mortality rates for duration of exposure
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Table 5. Adjusted excess lung cancer mortality rates/person-year for cohort continuously exposed to
arsenic (overall crude rate = 5.54 x 10-4
Exposure level Exposure duration Age at initial exposure
Category Rate x 10-4 Category Average Rate x 10-4 Category Average Ratex 10-4
Light 3.37 <10 yr 3.60 0.22 <20 17.9 0.76
Medium 9.54 10-19 14.0 0.97 20-29 24.3 2.87
Heavy 15.5 20-29 24.1 6.08 30-39 34.6 4.36
30-39 34.4 18.2 40-49 44.6 13.1
>40 yr 44.4 51.1 >50 54.5 71.1
13.4a 56.0a 14.5a
13.1b 49.1b 13-1b
aChi-square statistic for homogeneity.
bChi-square test statistic for trend.
show a similar increasing pattern, ranging from 0.22
x 10' for a duration of less than 10 years to 51.1 x
10' for a duration of 40 years or greater. The
categories for level of exposure also show an in-
creasing gradient of excess mortality, 3.37 x 10'
for the light category, 9.54 x 10' for the medium
category, and 15.5 x 10' for the heavy category. It
should be noted that the individuals in the medium
and heavy categories were not continuously ex-
posed to medium and heavy levels, but may have
been exposed for part of their employment to arse-
nic levels lower than their category definition.
Therefore, the differences in excess mortality rates
for this factor do not reflect the actual differences
among the three exposure levels. Figure 1 depicts
these relationships of excess mortality to the age at
initial exposure and duration of exposure. Figure 1
shows the observed cumulative excess mortality for
all exposure level categories combined as a function
of exposure duration in 10 year increments for four
of the age at initial exposure categories. Only those
points showing a positive excess mortality are
shown. The 40-49 age category is only shown up
through 30 years duration since there are few
person-years at risk beyond that point.
We also used GLIM to fit the actual functional
forms of the excess cancer risk predicted by the
multistage theory Eqs. (2) and (3)] to these data in
Table 3 using the average exposure duration and
age began exposure for each cell. The early-stage ef-
fect given in Eq. (2) resulted in a likelihood chi-
square goodness-of-fit of68.8, while the late-stage ef-
fect of Eq. (3) gave 55.0, both with 62 = 66 - 4 de-
grees of freedom. Clearly, the late-stage model pro-
vides the better fit. Since the excess cancer risk is
seen to be an increasing function of age at initial ex-
posure, we conclude that arsenic does not exert its
carcinogenic influence solely at the first stage, but
appears to act primarily at a late stage in the trans-
formation process. However, on the basis of these
data alone, we cannot rule out the possibility that
arsenic may influence both an early and late stage
of the process.
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FIGURE 1. Cumulative excess lung cancer mortality rates by
age at initial exposure.
For individuals whose exposure had stopped, i.e.,
those who terminated their employment, the multi-
stage theory predicts that their excess cancer risk
after cessation of employment will be an increasing
function of exposure duration and concentration,
and will also be independent of age started expo-
sure (if only the first stage is affected) or follow-up
time since exposure stopped (if only the penultimate
stage is affected). The indirect adjustment method
was applied to the data in Table 4 to produce excess
lung cancer mortality rates for each of these four
factors adjusted for the possible confounding effects
of the other three factors. These unconfounded
rates are given in Table 6. These results show that
the excess lung cancer mortality is an increasing
function of all four factors, and their associated test
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statistics, given in Table 6, are significant (one de-
gree of freedom chi-square tests for trend are 12.0
for exposure level, 35.5 for exposure duration, 4.5
for age began exposure, and 8.2 for time since expo-
sure stopped.) The adjusted excess lung cancer mor-
tality rates for age at initial exposure range from
3.37 x 10', for those who started employment be-
fore 20 years of age, to 28.2 x 10', for those who
started between 40 and 49 years of age. These rates
for duration of exposure range from 2.46 x 10 , for
a less than 10 year duration, to 76.3 x 10', for indi-
viduals having 40 or more years duration. The rates
for time since exposure stopped range from 7.06 x
104, for a period of less than 10 years, to 20.0 x
104, for a period of 20 or more years since exposure
stopped. The level of exposure factor also shows in-
creasing adjusted excess mortality rates, 7.33 x
10', 19.7 x 10' and 27.8 x 10' for the categories
light, medium and heavy respectively.
As before, we used GLIM to fit the functional
forms for excess cancer risk in Eqs. (4) and (5) to the
data in Table 4. This GLIM analysis produced likeli-
hood goodness-of-fit chi-square statistics of 105.6 by
using Eq. (4) (only an early-stage effect), and 102.2
by using Eq. (5) (only a late-stage effect), each statis-
tic having 140 = 144 - 4 degrees of freedom. Thus,
the late-stage model again provides a slightly better
fit but does not clearly discriminate between the
two hypotheses. Since the results in Table 6 show
the excess risk of death from lung cancer to be asso-
ciated with both age at initial exposure and time
since exposure ended, we conclude that arsenic does
not appear to exert its influence at only the penulti-
mate stage, but may also have an effect at an early
stage. A comparison of the adjusted rates in Table 6
shows that the effect of age at initial exposure upon
the excess lung cancer mortality risk appears to be
more pronounced than the effect of time since expo-
sure stopped, indicating that the late stage effect of
arsenic may be greater than the effect on an early
stage of the process.
Since these data do not clearly agree with a hy-
pothesis of arsenic acting solely at a late stage of
the transformation process, we used GLIM to exam-
ine the hypothesis that arsenic acts at both the first
and penultimate stages, but at possibly different
magnitudes relative to background. Under this hy-
pothesis, the multistage theory predicts that the ex-
cess age-specific cancer risk at age t = to + d + f
is given in Eq. (6):
E(t) -- ciri[(d + J)k-1*1] +
rk l[(d + to) k-1- tok-1] + rlrk ldk-l (6)
where, as before, c is the exposure concentration, to
the age at initial exposure, d the duration of expo-
sure, and f the follow-up time since exposure
stopped (which equals 0 for continuously exposed in-
dividuals). 'T'he constants r1 and rk 1 represent the
increased transition rate of the first and penulti-
mate stages relative to the background rates.
Therefore, the ratio rl/rk1l represents a measure of
the magnitude of the carcinogenic effect on the first
stage relative to the effect on the penultimate.
To obtain an estimate of this relative effective-
ness for arsenic, we used GLIM to fit Eq. (6) to all
the data combined in both Tables 3 and 4. The re-
sults for different ratios of rl/rk-l are shown in
Table 7. Table 7 also shows that the best fit to all
the data occurs for the model which assumes that
arsenic affects the first and penultimate stages
equally relative to their background occurrences,
i.e. rl/rk-l = 1.0. However, Table 7 also shows that
the model for which arsenic is a pure promoter, i.e.,
affects only the penultimate stage, does not fit
these data significantly poorer than the mixed ef-
fect model. These data (only 94.8 = 139 - 44.2 ex-
cess lung cancers) are apparently too limited to
clearly discriminate between the mixed effect and
pure effect hypotheses. Therefore, under this multi-
stage model of carcinogenesis, we conclude: (1) ar-
senic does not act solely at the first stage ofthe pro-
cess; and (2) arsenic does act at a late stage, but
may act at an earlier stage as well.
The final objective of this analysis is to use the
Table 6. Adjusted excess lung cancer mortality rates/person-year for cohort stopped
exposure to arsenic (overall crude rate = 9.98 x 10-4).
Exposure level Exposure duration Age at initial exposure Time since exposure stopped
Category Ratex 10-4 Category Average Ratex 10-4 Category Average Ratex 10-' Category Average Ratex 10-4
Light 7.33 10 yr 4.28 2.46 <20 18.1 3.37 <10 yr 3.73 7.06
Medium 19.7 10-19 14.2 10.2 20-29 24.4 7.43 10-19 13.0 18.0
Heavy 27.8 20-29 24.5 26.2 30-39 34.5 13.4 20 yr 20.8 20.0
30-39 35.6 37.0 40-49 44.6 28.2
.40 yr 46.9 76.3 >50 54.9 5.29
12.18a 41.93a 7.82a 8.33
11.98b 35.54b 4.53b 8.22
aChi-square test for homogeneity.
bChi-square test statistic for trend.
301Table 7. Comparison of goodness-of-fit statistics for mixture model assuming first and penultimate stages affected.
Relative effectiveness Likelihood goodness-of-fit
first stage/penultimate stage chi-square (205 d.f.)
a 179.8
ob 166.3
0.1 166.2
0.5 165.8
1.0 165.6
2.0 165.9
2.5 166.3
aonly first stage affected.
bonly penultimate stage affected.
Table 8. Estimated lifetime lung cancer mortality risk for hypothetical worker exposed to arsenic for 10-40 yr.a
Duration Only penultimate First and penultimate
of stage affected stages affected equally
exposure, yr Light exposure Heavy exposure Light exposure Heavy exposure
10 0.023 (106)b 0.027 (1.23) 0.028 (1.26) 0.046 (2.06)
20 0.028 (1.24) 0.044 (1.98) 0.033 (1.50) 0.067 (3.02)
30 0.037 (1.66) 0.080 (3.61) 0.042 (1.91) 0.102 (4.62)
40 0.051 (2.30) 0.133 (6.02) 0.057 (2.56) 0.156 (7.03)
aIndividual assumed to start exposure at age 20; U.S. white male age-specific mortality for 1950-1954 used in competing risk
calculations (5-yr age groups, 20-24 through 75-79).
bRatio of risk exposed individual/risk to unexposed individual (lifetime risk for unexposed = 0.022).
preceding results to assess the potential lifetime
risk to an individual exposed to arsenic in a manner
similar to this cohort of workers. To provide quanti-
tative estimates of lifetime risk, we have used the
results of the GLIM analysis which provide esti-
mates of the parameters in Eq. (6), specifically the
exposure concentration constants c, one for each ex-
posure level category. and the estimated exponent
k. This analysis produced maximum likelihood esti-
mates of k = 6.5 (which corresponds closely to the
estimate of k = 6.6 when fitting the background
model in Eq. (1) to the U.S. age-specific lung cancer
mortality for the period 1940-1965), and concentra-
tion constants as follows: for the model assuming
only a penultimate stage effect, the constants (x
1013) are 2.42, 6.13 and 9.81 for the light, medium
and heavy exposure categories, respectively; for the
model assuming an equal first and penultimate
stage effeci, i.e., r1 =rk 1 in Eq. (6), the constants (x
1013) are 2.17, 5.33 and 8.88, respectively.
Table 8 shows the estimated lifetime risk of
dying from lung cancer, up to age 80, for a
hypothetical worker beginning exposure at age 20
and continuing his exposure for 10-40 years, after
which his arsenic exposure would cease. These
lifetime risks are adjusted for competing risks from
other causes of death as described by Gail (18). The
data were grouped into 5-year age intervals, and
the background mortality from lung cancer and all
other causes were based on U.S. white males for
the calendar period 1950-1954, selected as
representing a central point for the cohort being
studied. Table 8 shows quantitatively how lifetime
risk depends upon the exposure concentration,
duration of exposure, and upon the presumed
mechanism of action. For 10 years exposure
duration to a heavy concentration, the lifetime risk
is almost doubled (0.046 vs. 0.027) if an effect at the
first stage of the carcinogenic process is added to an
effect at the penultimate stage. The multistage
theory predicts that if only the penultimate stage is
affected, then once exposure stops, the excess risk
remains constant at the level attained before
termination [see Eq. (5)]. However, if the first stage
is also affected, then the excess risk after exposure
termination first begins to level out, but then turns
around to increase once again as the excess
initiated cells move through the remaining stages.
As seen in Table 8, the impact of inclusion of a first
stage effect can be substantial, especially if the
exposure duration is relatively short.
Discussion
This methodology, based on a multistage theory
of carcinogenesis, allows interpretations of the
mechanism of action to be made concerning the find-
ings of an epidemiologic study by focusing on the
excess carcinogenic risk attributable to the carcino-
gen in question. The patterns of these excess risks
as they depend upon exposure duration, age at ini-
tial exposure, and time since exposure stopped, may
identify which stage(s) of the carcinogenic transfor-
mation process are affected.
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In our examination of a cohort study of smelter
workers exposed to arsenic, the results are compati-
ble with a mechanism of action that involves arsenic
acting at a late-stage of the process. In addition, we
have concluded that there may be a contribution to
an early stage effect, but the data are too limited to
clarify this hypothesis. The evidence that arsenic
acts at a late stage in the carcinogenic process is
provided by the relationship of increasing excess
lung cancer mortality risk with increasing age at
initial exposure. If arsenic is truely a late-stage car-
cinogen, then older individuals would be at greater
risk, since they have had time to accumulate more
cells in the earlier stages of the process, such cells
being particularly susceptible to the carcinogenic ac-
tion of arsenic. This relationship between age at ini-
tial exposure and excess cancer risk is also seen for
nasal sinus cancers in workers exposed to nickel
(19-21). Evidence for a predominately late stage ef-
fect of arsenic is also seen in the results of the
study of Pinto et al. (22) of retired smelter workers.
After retirement, the relative risk of respiratory
cancer death was found to decrease with increasing
age, or time since retirement. As shown by Day and
Brown (10), this is consistent with a late stage carci-
nogenic effect.
These data are not consistent with the hypothesis
that arsenic acts during the promotion and growth
period of the carcinogenic process, if we believe
that promotion and growth is reversible. As an ex-
ample of reversibility, in a study of DMBA induced-
PMA promoted skin tumorgenesis, Burns et al. (23)
found regression of tumors after termination of the
promoting agent. However, the epidemiologic data
studied here do not show such regression since the
excess lung cancer mortality risk remains even
after 20 years since the carcinogenic exposure pre-
sumably ceased (see Table 6). This was also found
by Pinto et al. (22) in their study of retired smelter
workers. This continuance of excess mortality risk
after termination of exposure indicates that arsenic
does not appear to affect the carcinogenic process in
a reversible manner, but rather may have an irre-
versible effect on a stage of the cellular transforma-
tion process. In addition, the relatively long latency
periods observed among individuals in this cohort
also argue against an effect on the promotion and
growth process. In animal experiments of the
initiation-promotion effect, this latency period is
often small, and most tumors appear within a short
time period since initiation of exposure to the
promoting agent. However, these data cannot
conclusively rule out an effect on the promotion and
growth process. In this instance, the growth period
may be much longer than this multistage theory hy-
pothesizes and may not be reversible. The observed
relationships of excess lung cancer mortality associ-
ated with duration of exposure and time since expo-
sure termination (Tables 5 and 6) are also consistent
with an effect on a slowly evolving growth process
which simply slows down when exposure is termi-
nated (note the difference in slopes of the excess
mortality with respect to time).
However, our mechanistic conclusions based on
the results of our analysis of this cohort study may
be biased by the lack of important relevant informa-
tion. Since no information on arsenic exposure prior
to this employment was obtained for the cohort, the
relationship of increasing excess risk with later age
at initial employment may be biased by previous ex-
posure to arsenic or other substances. These
workers who started employment at older ages may
have built up a prior exposure history dependent
upon the age at which they started this particular
employment. Thus, we cannot rule out the possibil-
ity that this finding is actually due to an increased
duration of prior exposure. Therefore, in any future
studies of occupational carcinogenesis, it is impor-
tant to obtain a complete work history to determine
any exposure prior to the particular employment
being studied.
This lack of exposure information is also impor-
tant to the examination of excess risk after expo-
sure ceases, i.e., employment is terminated. Our
findings indicate a moderately increasing risk with
time since employment ended, but this also may be
biased by individuals who have continued their ar-
senic exposure at another work site. Of the 69 lung
cancers found after ending employment at this
smelter, 19 individuals left work before the age of
50 and had at least five years follow-up before their
death. Since they were young enough to continue
employment, they may well have continued at
another work site associated with arsenic or other
substances, thus biasing the observed relationship.
An additional piece of important information con-
cerns the smoking history of these men. Smoking
histories were not available for the individuals in
this cohort. Therefore we could not directly adjust
our analysis for the effect of cigarette smoking.
However, we did examine this issue in the following
indirect manner. Since the cigarette smoking habits
of U.S. men have undergone substantial changes in
the past, the likelihood of an individual being a ciga-
rette smoker is associated with his calendar year of
birth. Therefore we recomputed the indirectly ad-
justed excess lung cancer mortality rates in Tables
5 and 6 by adjusting for calendar year of birth in ad-
dition to the other factors of interest. The calendar
year of birth categories we used are <1880,
1880-1889, 1890-1899, 1900-1909, and .1910. The
numbers of individuals, person-years at risk, ob-
303BROWNAND CHU
served and expected numbers of lung cancer
deaths, and indirectly adjusted excess lung cancer
mortality rates for these categories are shown in
Table 9 for both the continuously exposed and
stopped exposure groups. Table 9 shows that the
excess lung cancer mortality rates, adjusted for the
other factors, increase with later calendar years of
birth up to the last category, birth year >1910, at
which point the adjusted rates drop due to the few
cancer deaths observed for these individuals who
have not yet reached the ages at which lung cancer
mortality becomes more prevalent. This calendar
year of birth trend in the adjusted lung cancer mor-
tality is compared with the trend in background
lung cancer mortality for U.S. males in age groups
55-59 and 60-64 (13) in Figure 2. This figure shows
that the trends in background and excess lung can-
cer mortality are very similar, indicating that the
factor, presumably cigarette smoking, affecting the
background mortality is affecting the excess mortal-
ity in a similar manner. Adjusting for calendar year
of birth had little effect on the adjusted excess lung
cancer mortality rates for the other factors of inter-
est. The effect on arsenic exposure category was un-
changed, while the effect on age at initial exposure
and duration of exposure was to make the relation-
ships slightly more pronounced. Therefore, this indi-
rect examination of the possible confounding effects
of cigarette smoking indicates that smoking may
not be a major confounder of our analysis. However,
we emphasize that this examination is indirect and,
as such, does not provide conclusive evidence of the
lack of a confounding effect. In their studies of
smelter workers exposed to arsenic, Rencher et al.
(24) and Pinto et al. (22) concluded that smoking did
not seriously confound their results; however, the
effect of smoking as a confounding factor in our par-
ticular analysis cannot be completely ruled out.
As noted in other epidemiologic studies of
smelter workers exposed to arsenic, the role of
other atmospheric contaminants is difficult to mea-
sure. The original Lee and Fraumeni (8) study of
these data could not distinguish the influence of ar-
senic from other agents, most notably sulfur diox-
ide, which were correlated with the levels of arsenic
in the smelting process. Therefore, due to this high
correlation, we cannot categorically state that
arsenic alone is the active carcinogenic agent.
Presently, arsenic trioxide and related com-
pounds are the only suspect human carcinogens
which have not clearly been shown to be carcino-
genic in experimental animals. In over 20 animal ex-
periments, arsenic by itself or in combination with
known carcinogens was not found to be carcinogenic
(25). Of these studies, four were cocarcinogenesis
studies involving trivalent arsenic.
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FIGURE 2. Excess and background lung cancer mortality
rates by calendar year of birth.
Table 9. Number of individuals, person-years at risk, observed and expected number of lung cancer deaths, and
adjusted excess lung cancer mortality rate by calendar year of birth.
Calendar
yr. Number of Person-yr No.lung cancerdeaths Adjusted excess
Exposure of birth persons at risk Obs. Exp. mortality rate x 104
Continuously exposed group <1800 427 2891.7 9 1.57 2.60
1880-1889 590 6545.7 15 4.45 4.99
1890-1899 892 11328.8 26 7.07 12.5
1900-1909 1615 20739.6 20 7.18 14.0
> 1910 4490 43867.3 0 2.41 0.0
Stopped exposure group <1880 299 2001.7 9 1.69 10.2
1880-1889 423 3452.4 18 5.22 18.9
1890-1899 597 5279.7 19 6.86 23.1
1900-1909 754 9041.6 20 5.17 28.0
>1910 2603 27741.7 3 2.61 0.49
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Baroni et al. (26) studied arsenic trioxide admin-
istered in drinking water to Swiss mice after initia-
tion with either a single skin application of DMBA
or gavage administration of urethane. Histopathol-
ogy was performed on the major organs, including
the lung, the target site of the occupational carcino-
genesis studies. Urethane, by itself, was shown to
induce lung adenomas, but the cocarcinogenic activ-
ity of arsenic was found to be negative. Unfortu-
nately, all the animals treated with both urethane
and arsenic trioxide died before the 50th week.
Thus, the exposure to arsenic may not have been of
sufficient duration to adequately study its pre-
sumed promotional or late stage effect. Boutwell
(27) found no cocarcinogenic activity of potassium
arsenite in skin carcinogenesis after a single skin
application of DMBA. Sanderson (28) and Milner (29)
also studied the cocarcinogenesis effects of arsenic
in skin carcinogenesis with similarly negative re-
sults.
The evidence that arsenic compounds produce
mutational effects in bacteria is inconclusive. How-
ever, these compounds have been shown to induce
chromosomal aberrations in mammalian cells (25). In
addition, a number of epidemiologic studies have
shown an increased incidence of chromosomal aber-
rations in patients treated with arsenical com-
pounds (30-32) and in workers occupationally ex-
posed in a smelter environment (33, 34). Brusick (35)
states that chromosomal aberrations are manifesta-
tions of DNA damage and genotoxicity. Thus, these
findings provide evidence that arsenic may involve
the cellular transformation period of the carcino-
genic process.
Statistical Appendix
Computation ofAdjusted Rates
We wish to compare the excess mortality rates
among the different categories of one factor while
adjusting for the possible confounding by other
factors. To accomplish this, we use an extension of
the method of Mantel and Stark (14) for the com-
putation of indirect-adjusted rates. This method is
based on an iterative procedure in which the
"standard" rates used in the indirect adjustment
are derived internally from the data since no
relevant external standard exists. In the case of
overall-as opposed to excess-mortality or mor-
bidity rates, this method has been shown to give
maximum likelihood estimates of the rates in a
product model (36, 37). In our situation we use the
method to estimate excess mortality rates, i.e. the
difference in rates between observed and expected
(based on some external standard).
For a three-factor situation, a description of this
term illustrating the methodology in mathematical
notation is as follows. Let O°-k denote the observed
number of responders,Eijk die expected number of
responders (based on an external standard such as
the age, race, sex, calendar period-specific U.S. mor-
tality rates for the disease of interest), andNijk the
person-years at risk in the ith category of factor 1,
thejth category of factor 2, and the kth category of
factor 3. Also letR
R =V°ijk-EiJk)IXNijk
denote the crude overall excess mortality rate per
person year, andRli(i= 1, ... I), R2(j= 1, ..., J), and
R3k(k = 1, ..., K) denote theadjustea excess rates for
each ofthe three factors,respectively.
In the case of three factors, the indirect-adjust-
ment procedure consists of a series of three sets of
computations, the series being performed iterative-
ly until each set of rates stabilizes, i.e., when each
combination of two sets implies the third set and no
further changes would be made. We begin this se-
ries of computations by obtaining the rates for fac-
tor 1 adjusted for the other two factors (we must
assume some set of initial rates for the adjustment
factors; we use the crude rates but any rates will
suffice). The adjusted rate for the ith category of
factor 1 is given by,
Rli=R 7-7 DijklIyl R2jR3Nvk i=1,...,I
jk ~jk jRkzk i t..
=RDi..IXi..
where Dijk =0ijk -Eijk represents the excess
number of responders in category (ijk). ThusRli is
simply the crude excess rate multiplied by the ratio
of the actual excess number of responders, Di , to
the expected excess,Xi , based on the ratesR2 and
R3kfor the other two factors.
The next computation in this series is to compute
the adjusted rates for factor 2,
R2j=RXXYDijk/fRR li3kNj itk i k li3 jk j=1, .. .,J
where the R1l, i = 1, ..., I, are derived from the
first step. The final computation in the series is to
compute the adjusted rates for factor 3 which are
based on the rates computed in the previous two
steps. In order to insure that the adjusted rates are
nonnegative, if, during any step in this series, the
adjusted rates are estimated to be negative, they
are set equal to zero.
Upon convergence, which we define as the maxi-
mum relative change in rates being smaller than
some critical value such as 10', the rates are de-
pendent upon the assumed initial set of rates and
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may not imply a total expected number of excess
deaths that is equal to the total observed. Following
Mantel and Stark, we make a final adjustment by
multiplying each rate by a correction factor of
I0/I-E where
so =E IDijk
i k
denotes the total observed excess deaths and 1 E
denotes the total expected excess deaths implied by
the convergent rates. The total expectations im-
plied by the factor 1 rates is
(XE)1=i aXRliNlijk
by the factor 2 rates is
(XE)2 = zR2N2ijk
and similarly for (IE)3. This final modification in-
sures that each set of adjusted rates imply a total
expectation equal to the total observed. These are
the rates shown in Tables 5, 6 and 9.
Tests for Equality of Adjusted Rates
The Mantel-Stark method is useful for estimating
the excess rates for each factor adjusted for the
other factors, but does not provide a means for any
hypothesis test, such as equality or significance of a
trend. The following section proposes such tests
based on score statistics obtained from the assumed
Mantel-Stark product model for the excess risk.
Assume we wish to test the equality or trend of
the excess rates for one factor having I categories,
adjusted for, or stratified by another factor having
J categories. Note that this adjustment or
stratification factor may be a combination of more
than one factor (e.g., two adjustment factors having
5 and 3 categories respectively would produce one
combination factor with 5 x 3 = 15 categories). Let
Oij E- and N.1 denote the observed number of
responaers, the expected number of responders,
and the person-years at risk for category i of the
factor of interest and categoryj of the stratification
factor. Then, under an assumed product model for
excess risk, Oj, is distributed as a Poisson variate
with mean ESj + N-1expfai + Pj}, where expfai},
i = 1, . . ., I, are the excess rates for the factor of
interest, and exp{i},j = 1,... , J the rates for the
stratification factor. One null hypothesis of interest
is
Ho: ai = a i = 1, . . . , I
i.e., the excess risk does not depend upon the factor
of interest. The unknown constant risk, exp{a}, can
be included into the Pj since we have assumed a
product model, therefore, without any loss of
generality, this null hypothesis also be considered
as
Ho:ai = O
We propose to test this hypothesis by score
statistics (38, 39). The logarithm of the likelihood of
the observed data is
logL = I I[Oijlog(Eij+Nijexp {ai + 3lS})
-(Eij+Nijexp{ai+i3j})]
The score statistics for the ai are the first partial
derivatives of log L evaluated under the null
hypothesis ai = 0 and pi = A.its maximum likeli-
hood estimate,
S(ai) d logL
ai A
ai= ,pi=pi
= INijexp{A} ( j )
ij+Ni,jexpfn}
These score statistics S(ad), S(a2) ..., S(a1) are
asymptotically normally distributed under Ho with
mean zero and covariance matrix, conditional on
P(j=(j, given by
X aa= 7aa 1a13o1313"l/3a
where Xaa is an I x I diagonal matrix, the ith
element of thediagonal being
-E [d21ogL] a| = 0,131=/i = (N jexp{fi})2
L dai __1j ai = °.pi=pi j Eij +NijeXPpj}A
Eal is an I x Jmatrix, the(tj)th element being -1 ~~~~~~~~~~~A
-E Id2logL WiANexp{3jP})2
Ldaidflj ai = O,Pj= j Ei.+Nijexp{fj}
and Xpp is a J x J diagonal matrix, the jth
element of the diagonal being
-E d2logL] (N,eexp{Ii,})A
dpj2 ai = 0,,=pi i Eij+Nijexp{fj}
Therefore, by letting
Cij = Nijexp{f })2lEij+Nijexp{i31})
the ((j)th element ofX*aa becomes
j=i
*o i {- (CikCjk1C.k)
k
where ci. =Xcij and c .= -c
.71 t
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Since theS(ai), i = 1, * * * I, are linearly dependent,
i.e., XS(a) = 0, a test of the null hypothesis can be
based on the asymptotic chi-square statistic,
S I-1 T*I-1 SI-1
where SI-1 is a vector of any I - 1 elements ofS(ai),
i= 1, ... , I and *I-1 is the corresponding covari-
ance matrix obtained from V;*aa Under the null
hypothesis, this statistic is distributed as a central
chi-square variate with I - 1 degrees offreed m.
However, to compute this statistic, the f1 must
first be computed from the first partial derivative of
the log likelihood,
dlogL a= =exp{ff31}N.,[~+NjepI1
dpj | ° {}ti Ei +Nijexpfpl }I
Setting this derivative to zero leads to the equation
xP{/@1}
L [Eijex{plf } +Nij] /
which can be solved iteratively for Ai, by evaluating
the right-hand side for some initial value of
solving for a new Aj, and contiiuing the iteration
until covergence. The value of Pj obtained by this
procedure will be the maximum likelihood estimate
of Pi and can be used in the evaluation of the chi
square test statistic.
It should be noted that when this score statistic
is applied to overall mortality rather than excess
mortality, i.e., by treatingEij = 0, then
and f,j= O °ijj Nij= O.j/N.j
M(ai)= (°ij -NijOjlN.j.)
the Mantel-Haenszel deviation between the oW
served and expected numbers of responders sum-
med overthestratification factor. Theonly difference
between this score statistic method and the Mantel-
Haenszel approach is in the calculation of the
covariance matrix where the score statistic method
uses Nj3 and the Mantel-Haenszel method uses
NNWj-1) in the denominator of the summed
covariance terms (40).
A score statistic test for trend can also be
derived from the log likelihood,
log L = -O-,[log(Eij+Nijexp{Xi+(3jl)
(Eij+Nijexp{aXi + 13))]
where Xi represents a value associated with cate-
gory i of the factor of interest. The null hypothesis
in this case is HN: a= 0, i.e., no trend of excess risk
with the variable X. The score statistic for a can be
written as
S(a)= d logL L
da a = [o.
= XXjS(ai)
i.e., a weighted sum of the individual score statistics
S(ai), i = 1, ..., I. It should be noted that the
maximum likelihood estimates (j, j = 1, ... , J are
the same as in the previous derivation. Therefore,
under Hog S(a) is asymptotically normally distri-
buted with mean 0 and variance
a2= yX X.Xo..
Therefore, a one degree of freedom chi-square test
for trend can be based on the statistic S2(a)/o2.
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